Access our 2024 TIDES Europe Investor Recap Call

Codexis, Inc.

Codexis Unveils Pioneering Enzymatic Synthesis Data at TIDES Europe 2024

Company showcases four routes of synthesis for approved siRNA therapeutic asset and demonstrates superiority of double-stranded RNA ligases compared to wild-type enzymes

View Details Here

Codexis, Inc.

Q3 2024 Codexis, Inc. Earnings Conference Call

October 31, 2024 - 4:30 PM ET

Learn More   Webcast

Enabling the Exponential Expansion of
RNAi Therapeutics.

We have a 20-year history of engineering exquisite enzymes for complex challenges

Codexis was founded with the simple idea that we could engineer enzymes better than anyone else. Through our CodeEvolver® technology, we solve problems our customers can’t overcome using traditional chemical processes for pharmaceutical biocatalysis and enzymatic siRNA manufacturing. Today, we are transforming into the leading enzymatic siRNA manufacturing company to support both small molecule and oligonucleotide therapeutics developers.

Our Solutions

We provide process development capabilities and scalable and efficient manufacturing services using our proprietary enzymatic technologies

Pharmaceutical Biocatalysis

Pharmaceutical Biocatalysis

Codexis offers a full range of enzyme panels and screening kits as well as custom R&D support to deliver high-quality, engineered enzyme solutions.

View Details

Pharmaceutical Biocatalysis

Codexis offers a full range of enzyme panels and screening kits as well as custom R&D support to deliver high-quality, engineered enzyme solutions.

RNA Manufacturing

RNA Manufacturing

Codexis offers scalable and efficient enzymatic processes for siRNA manufacturing. With multiple enzymatic pathways to synthesize siRNA, you can choose the option that best meets your needs.

View Details

RNA Manufacturing

Codexis offers scalable and efficient enzymatic processes for siRNA manufacturing. With multiple enzymatic pathways to synthesize siRNA, you can choose the option that best meets your needs.

Our Technology

Our company is built upon our proprietary CodeEvolver technology, which is unmatched in tailoring enzyme performance for specific applications and processes. Our newest platform—the ECO Synthesis™ manufacturing platform—has the potential to revolutionize oligonucleotide manufacturing with enzymatic processes.

Our Culture

Our people know they are working on something no other company can do.

We are combining our decades of experience in machine learning and artificial intelligence with the best engineers in the business to enable the exponential expansion of RNAi therapeutics. We are at the forefront of a technological revolution in healthcare and are excited by the potential of our collective future. Learn more about what it means to be a Codexian.

Learn More

We enable scalable and efficient manufacturing of complex therapeutics.

Our enzymatic tools and platforms enable the scalable and efficient manufacture of small molecule API and siRNA for our customers while reducing costs and time of manufacturing. Contact us today to learn more about how we can help you scale your capabilities.

Contact us